Lupin Limited - Asset Resilience Ratio

Latest as of March 2026: 9.32%

Lupin Limited (LUPIN) has an Asset Resilience Ratio of 9.32% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Lupin Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs35.77 Billion

≈ $386.85 Million USD Cash + Short-term Investments

Total Assets

Rs383.65 Billion

≈ $4.15 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2026)

This chart shows how Lupin Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Lupin Limited assets under control.

Liquid Assets Composition Over Time

This chart breaks down Lupin Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Lupin Limited to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs35.77 Billion	9.32%
Total Liquid Assets	Rs35.77 Billion	9.32%

Asset Resilience Insights

Limited Liquidity: Lupin Limited maintains only 9.32% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Lupin Limited Industry Peers by Asset Resilience Ratio

Compare Lupin Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Lupin Limited (2012–2026)

The table below shows the annual Asset Resilience Ratio data for Lupin Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	9.32%	Rs35.77 Billion ≈ $386.85 Million	Rs383.65 Billion ≈ $4.15 Billion	+4.37pp
2025-03-31	4.95%	Rs14.46 Billion ≈ $156.40 Million	Rs292.05 Billion ≈ $3.16 Billion	+0.82pp
2024-03-31	4.13%	Rs9.91 Billion ≈ $107.17 Million	Rs239.97 Billion ≈ $2.60 Billion	+1.19pp
2023-03-31	2.94%	Rs6.74 Billion ≈ $72.92 Million	Rs229.56 Billion ≈ $2.48 Billion	-1.71pp
2022-03-31	4.65%	Rs10.14 Billion ≈ $109.70 Million	Rs218.21 Billion ≈ $2.36 Billion	-5.77pp
2021-03-31	10.42%	Rs24.59 Billion ≈ $265.98 Million	Rs236.10 Billion ≈ $2.55 Billion	+0.64pp
2020-03-31	9.78%	Rs24.43 Billion ≈ $264.16 Million	Rs249.84 Billion ≈ $2.70 Billion	+2.08pp
2019-03-31	7.69%	Rs21.51 Billion ≈ $232.57 Million	Rs279.49 Billion ≈ $3.02 Billion	+6.50pp
2018-03-31	1.20%	Rs3.15 Billion ≈ $34.03 Million	Rs263.05 Billion ≈ $2.84 Billion	-6.92pp
2017-03-31	8.11%	Rs21.59 Billion ≈ $233.50 Million	Rs266.07 Billion ≈ $2.88 Billion	+8.06pp
2016-03-31	0.05%	Rs120.20 Million ≈ $1.30 Million	Rs226.25 Billion ≈ $2.45 Billion	-12.55pp
2015-03-31	12.60%	Rs16.56 Billion ≈ $179.08 Million	Rs131.38 Billion ≈ $1.42 Billion	+10.88pp
2014-03-31	1.73%	Rs1.76 Billion ≈ $19.08 Million	Rs102.06 Billion ≈ $1.10 Billion	+1.73pp
2012-03-31	0.00%	Rs1.50 Million ≈ $16.22K	Rs79.82 Billion ≈ $863.25 Million	--

pp = percentage points

About Lupin Limited

NSE:LUPIN India Drug Manufacturers - Specialty & Generic

Market Cap

$10.20 Billion

Rs943.37 Billion INR

Market Cap Rank

#2194 Global

#92 in India

Share Price

Rs2063.20

Change (1 day)

-1.52%

52-Week Range

Rs1905.60 - Rs2514.80

All Time High

Rs2514.80